Kvika banki hf.: Ann
Kvika banki hf.: Announcement from Kvika's Nomination Committee regarding candidacy for the Board of Directors
January 09, 2025 08:20 ET | Kvika banki hf.
Kvika banki hf.'s („Kvika“ or „the Company“) Nomination Committee (“the Committee”) invites those interested to submit their nominations or candidacies to the to the Board of Directors of the Company...
RSC Horizontal Grey-01.png
Russell Square Completes Phase 1 of The Highlands at Silverdale, Delivering 234 Units
January 09, 2025 08:15 ET | Russell Square
Russell Square completes Phase 1 of The Highlands at Silverdale, delivering 234 luxury apartments to Kitsap County.
Middlefield Canadian Income PCC: Net Asset Value(s)
January 09, 2025 08:07 ET | Middlefield Canadian Income PCC
Middlefield Canadian Income PCC Net Asset Value Middlefield Canadian Income PCC Middlefield Canadian Income - GBP PC (a protected cell company incorporated in Jersey with registration number...
AI Unlimited Group Unveils 2025 Vision for Integrated AI-Powered Ecosystem
January 09, 2025 08:06 ET | AI Unlimited Group, Inc.
LOS ANGELES, Jan. 09, 2025 (GLOBE NEWSWIRE) -- AI Unlimited Group Inc. (AIUG) is accelerating its mission to revolutionize how users interact with technology by unveiling its 2025 vision: a fully...
sns insider pvt ltd.png
Microbiome Therapeutics Market Size to Surpass USD 1782.9 Million by 2032, Growing at a 31.1% CAGR – SNS Insider
January 09, 2025 08:05 ET | SNS Insider pvt ltd
Pune, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Microbiome Therapeutics Market Size & Growth Analysis: “According to SNS Insider, The Microbiome Therapeutics Market was valued at USD 156.1 million in...
UNITI_50632_Uniti_Parent_Logo_RGB.png
Uniti Group Inc. Announces Launch of Fiber Securitization Notes Offering
January 09, 2025 08:05 ET | Uniti Group Inc.
LITTLE ROCK, Ark., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that Uniti Fiber ABS Issuer LLC and Uniti Fiber TRS Issuer LLC,...
IO Biotech.jpg
IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer
January 09, 2025 08:05 ET | IO Biotech
-- Enrollment Completed Ahead of Schedule --       -- Initial Data Expected in 2025 -- NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...
Net Asset Value(s)
January 09, 2025 08:05 ET | Octopus AIM VCT PLC
Octopus AIM VCT plc Net Asset Value Octopus AIM VCT plc announces that as at 31 December 2024 the unaudited net asset value of the Ordinary shares was approximately 52 pence per share. The net...
Net Asset Value(s)
January 09, 2025 08:05 ET | Octopus AIM VCT 2 plc
Octopus AIM VCT 2 plc Net Asset Value Octopus AIM VCT 2 plc announces that as at 31 December 2024 the unaudited net asset value of the Ordinary shares was approximately 40.7 pence per share. ...
22157.jpg
Impact Modifiers Global Market Outlook 2025 - Automotive Sector Drives 5.7% CAGR in Impact Modifiers
January 09, 2025 08:04 ET | Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Impact Modifiers: Global Markets" report has been added to ResearchAndMarkets.com's offering. The Global Impact Modifiers Market was valued at USD...